Clinical Trials Logo

Poor Ovarian Reserve clinical trials

View clinical trials related to Poor Ovarian Reserve.

Filter by:
  • None
  • Page 1

NCT ID: NCT05602090 Recruiting - Clinical trials for Poor Ovarian Reserve

Growth Hormone For Poor Ovarian Reserve Patients in ICSI Trials

Start date: February 1, 2022
Phase: Phase 2/Phase 3
Study type: Interventional

Effect of Growth Hormone Adjuvant Therapy on ICSI Trials For Poor ovarian Reserve Patients

NCT ID: NCT04797377 Completed - Clinical trials for Poor Ovarian Reserve

Autologous Intraovarian Platelet Rich Plasma Treatment in Women With Poor Ovarian Response

Start date: March 16, 2021
Phase: N/A
Study type: Interventional

Reproductive age women diagnosed with poor ovarian response (POR) based on Bologna criteria with a history of at least two prior failed ICSI cycle will be recruited for the study. Antral follicle count (AFC), serum anti-mullerian hormone (AMH), and early follicular phase serum follicle stimulating hormone (FSH) levels will determined at baseline. Autologous blood obtained from peripheral vein will be used to prepare PRP following standard protocols and will be injected to both ovaries. Ovarian reserve parameters and ICSI outcomes will be determined.

NCT ID: NCT04588844 Not yet recruiting - Clinical trials for Poor Ovarian Reserve

Effect of Growth Hormone Injection on the IVF/ICSI Outcome of Patients With Poor Ovarian Reserve.

Start date: December 1, 2020
Phase: N/A
Study type: Interventional

Declined fertility and ovarian reserve in older women are associated with lower density of Growth hormone (GH) receptors and dysregulation in GH secretion. GH can regulate the expression of growth hormone receptor and strengthen the function of mitochondria, which could improve the quality of the female oocyte. In this study, a prospective randomized control will be conducted to explore the effect of GH adjuvant therapy on clinical outcome of in vitro fertilization.

NCT ID: NCT04224818 Completed - Clinical trials for Poor Ovarian Reserve

Dual Trigger in the Final Oocyte Maturation in Poor Ovarian Responders

Start date: July 11, 2018
Phase: Phase 3
Study type: Interventional

This is a randomized controlled clinical trial to investigate the effect of dual trigger (hCG and GnRH agonist) on the final oocyte maturation compared to the standard hCG trigger in patients with poor ovarian reserve seeking IVF/ICSI treatment.

NCT ID: NCT01204840 Completed - Infertility Clinical Trials

Growth Hormone for Poor Responders in in Vitro Fertilization (IVF)

Start date: September 2010
Phase: Phase 2
Study type: Interventional

The purpose of this study is to determine if growth hormone given 4 weeks before as well as during a cycle of in vitro fertilization will improve outcomes in women who have had previous failure with IVF treatment cycles using high doses of follicle stimulating medications and had a poor response (less than 6 follicles).